Skip to content
Archive of posts filed under the Zocor and Vytorin category.

Zocor and Vytorin Safety: Resources from FDA

In June 2011, the US Food and Drug Administration (FDA) released information connecting 80mg doses of cholesterol drugs Zocor and Vytorin to muscle damaging conditions myopathy and rhabdomyolysis. Learn more about the FDA’s decision through these resources: Safety Alert General warning info geared toward doctors and pharmacists who prescribe simvastatin drugs like Zocor and Vytorin. [...]

Rhabdomyolysis: Cause, Symptoms, & Relationship to Zocor & Vytorin

What is rhabdomyolysis? What are the symptoms? How is it treated? Rhabdomyolysis (rhabdo) occurs when damaged skeletal muscles leak a protein called myoglobin into the bloodstream. Skeletal muscles are the muscles related to bodily movement at the joints. When they are traumatized by some injury or other cause, they release the contents of their cells, [...]

What is Myopathy? How Does It Relate to Zocor / Vytorin?

What is myopathy? What are the symptoms? How is it treated? “Myopathy” refers to muscle disease. It is a group of disorders that affect the functioning of muscle fibers and, as a result, cause muscular weakness. Because myopathy includes multiple disorders, symptoms can vary from temporary muscle cramps to total paralysis. The most serious symptoms [...]

Follow-up to Zocor and Vytorin Press Release

As you may have read in yesterday’s press release, we are taking cases related to the cholesterol drugs Zocor and Vytorin. These two pharmaceuticals are statins, which means they are used to lower cholesterol. Statins can have rare but serious adverse side effects involving muscle damage. The FDA has connected the 80mg dose of Zocor [...]

Press Release: Zocor and Vytorin

FOR IMMEDIATE RELEASE Memphis Law Firm Takes on Cases Against Zocor and Vytorin As of this week, Memphis personal injury firm Darrell Castle & Associates PLLC is pursuing cases against the cholesterol drugs Zocor and Vytorin. Anyone who has taken Zocor or Vytorin and been diagnosed with myopathy or rhabdomyolysis qualifies for a case evaluation [...]